Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för diarsenic trioxide. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2015-01-28

Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet.

Lengfelder E, Lo-Coco F, Ades L, Montesinos P, Grimwade D, Kishore B, Ramadan SM, Pagoni M, Breccia M, Huerta AJ, Nloga AM, González-Sanmiguel JD, Schmidt A, Lambert JF, Lehmann S, Di Bona E, Cassinat B, Hofmann WK, Görlich D, Sauerland MC, Fenaux P, Sanz M, European LeukemiaNet.

Leukemia · journal article · DOI 10.1038/leu.2015.12

Bibliografisk träff 2015-01-11

Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy.

Jiao G, Ren T, Guo W, Ren C, Yang K.

Tumour Biol · research support, non-u.s. gov't; journal article · DOI 10.1007/s13277-015-3040-z

Bibliografisk träff 2014-11-28

Arsenic trioxide suppresses transcription of hTERT through down-regulation of multiple transcription factors in HL-60 leukemia cells.

Zhang Y, Sun M, Shi W, Yang Q, Chen C, Wang Z, Zhou X.

Toxicol Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.toxlet.2014.11.028

Bibliografisk träff 2014-11-10

Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.

Dogra S, Bandi S, Viswanathan P, Gupta S.

Cancer Lett · research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.canlet.2014.11.008

Bibliografisk träff 2014-07-18

Elevated levels of antibodies against xenobiotics in a subgroup of healthy subjects.

Vojdani A, Kharrazian D, Mukherjee PS.

J Appl Toxicol · research-article; journal article · DOI 10.1002/jat.3031

Bibliografisk träff 2014-06-28

Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells.

Li H, Wang Y, Xu W, Dong L, Guo Y, Bi K, Zhu C.

Acta Haematol · research support, non-u.s. gov't; journal article · DOI 10.1159/000362683

Bibliografisk träff 2007-02-01

[Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia].

Lengfelder E, Schultheis B, Büchner T, Hehlmann R.

Dtsch Med Wochenschr · review; journal article · DOI 10.1055/s-2007-959329

Bibliografisk träff 2006-12-20

Arsenic trioxide, a potent inhibitor of NF-kappaB, abrogates allergen-induced airway hyperresponsiveness and inflammation.

Zhou LF, Zhu Y, Cui XF, Xie WP, Hu AH, Yin KS.

Respir Res · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/1465-9921-7-146

Bibliografisk träff 2001-11-01

Arsenic trioxide is a potent inhibitor of the interaction of SMRT corepressor with Its transcription factor partners, including the PML-retinoic acid receptor alpha oncoprotein found in human acute promyelocytic leukemia.

Hong SH, Yang Z, Privalsky ML.

Mol Cell Biol · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/mcb.21.21.7172-7182.2001